Background: Dementia with Lewy bodies (DLB) is a heterogeneous disease in which clinical
presentation, symptoms, and evolution widely varies between patients. Objective: To …

Objective To investigate whether concomitant Alzheimer's disease (AD) pathology, reflected
by cerebrospinal fluid (CSF) biomarkers, has an impact on dementia with Lewy bodies …

Lewy Body and Parkinsonian Dementia - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Objective Lewy body dementias (LBD) include both dementia with Lewy bodies (DLB) and
Parkinson's disease with dementia (PDD), and the differentiation of LBD from other …

Background and purpose: To investigate whether there may be differences in the clinical
course and changes in cognitive progression between dementia with Lewy bodies (DLB) …

Dementia with Lewy bodies (DLB) is the second most common cause of degenerative
dementia after Alzheimer's disease (AD), and is clinically characterized by the progressive …

Publisher Summary This chapter emphasizes that dementia with lewy bodies (DLB) is a
common form of neurodegenerative dementia. The term DLB is a clinical syndrome and not …

The aim of this article is to describe the 2017 revised consensus criteria for the clinical
diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic …

To determine if Alzheimer's disease (AD), its Lewy body (LB) variant (LBV), and diffuse LB
disease (DLBD) are distinguishable at initial clinical evaluation, data from autopsy …

Objectives Dementia with Lewy bodies (DLB) accounts for 10%–15% of dementia cases at
autopsy and has distinct clinical features associated with earlier institutionalisation and a …